Is the INGR1D2 study right for me and my baby? 

The INGR1D2 study aims to screen newborn babies to discover which babies are at highest genetic risk of developing Type 1 Diabetes.  You can find our more about INGR1D2 here.

The INGR1D2 study would give you information about your baby's risk of developing Type 1 Diabetes.  It will not tell you whether your baby definitely will or will not develop the condition, only whether there is an increased chance.  There is currently no routinely available additional care, treatment, or monitoring available for babies identified as being at higher genetic risk of Type 1 Diabetes.  You would, however, have the opportunity to enrol your baby in a further study looking at ways to prevent Type 1 Diabetes from developing in babies at higher risk.  

How do you feel about finding out whether your baby is at higher risk of developing Type 1 Diabetes?

 Please click the button below that best reflects how you feel.